Barbara A. Cornblatt
Alma materBaruch College, New School University
Occupation(s)Professor at Hofstra Northwell School of Medicine, Investigator at Center for Psychiatric Neuroscience and The Feinstein Institute for Medical Research, Director of the Recognition and Prevention Program
AwardsJoseph Zubin Memorial Fund Award (1996)

Barbara A. Cornblatt is Professor of Psychiatry and Molecular Medicine at Hofstra Northwell School of Medicine.[1] She is known for her research on serious mental disorders, with a specific focus on psychosis and schizophrenia.[2][3] Her efforts to find treatments to help youth with mental illness led to the development of the Recognition and Prevention Program, which she founded in 1998.[4]

Cornblatt was awarded the Joseph Zubin Memorial Fund Award in 1996.[5] She served as president of the Society for Research in Psychopathology (2000-2001).[6]

Biography

Cornblatt received an MBA degree in industrial psychology at Baruch College, City University of New York in 1977 and a Ph.D. in experimental psychology from New School University in 1978.[1]

Cornblatt's research program, including projects focusing on cognitive behavioral social skills training for youth at risk of psychosis,[7] predictors and mechanisms of conversion to psychosis,[8] and characterization of prodromal schizophrenia,[9] has been funded by the National Institute of Mental Health of the National Institutes of Health. She worked on North American Prodrome Longitudinal Study (NAPLS-1), a large multisite longitudinal study focusing on the earliest stages of psychotic illness,[10] with prominent clinical psychologists and psychiatrists including Tyrone Cannon, Elaine F. Walker, and Thomas McGlashan.[11][12]

Research

Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: In this study, the researchers looked at different analytes found in human blood plasma. These plasma analytes reflected inflammation, oxidative stress, hormones, and metabolism. It was discovered that individuals who are at a high-risk for psychosis have high levels of inflammation, oxidative stress, and hormone imbalances.[13]

Cortisol Level and Risk for Psychosis: Researchers tested the cortisol contents of saliva in 256 individuals. It was discovered that patients that were at a higher risk of psychosis, or already had the diagnosis, had increased cortisol levels. This study suggests the need for future research focusing on the hormone levels of individuals with, or at risk of, psychosis.[14]

Functional development in clinical high risk youth: Prediction of schizophrenia versus other psychotic disorders: This study was a follow-up study involving participants from the NAPLS-1 study. Researchers checked for three different signs in their patients: psychosis-risk symptoms present at baseline (these plasma analytes reflected inflammation, oxidative stress, hormones, and metabolism), onset of psychosis during the two and a half-year follow-along period of NAPLS-1, and psychotic disorder diagnosis from the Diagnostic and Statistical Manual of Mental Disorders (DSM). The study showed that people in early adolescence who showed poor social indicators were four times as likely to develop schizophrenia. Those in their late adolescence with poor social indicators were five times as likely to develop schizophrenia.[15]

Representative publications

  • Cornblatt, B. A., Auther, A. M., Niendam, T., Smith, C. W., Zinberg, J., Bearden, C. E., & Cannon, T. D. (2007). Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophrenia Bulletin, 33(3), 688–702.
  • Cornblatt, B. A., & Erlenmeyer-Kimling, L. (1985). Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity. Journal of Abnormal Psychology, 94(4), 470–486.
  • Cornblatt, B. A., & Keilp, J. G. (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophrenia Bulletin, 20(1), 31–46.
  • Cornblatt, B. A., Lenzenweger, M. F., & Erlenmeyer-Kimling, L. (1989). The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Research, 29(1), 65–85.
  • Cornblatt, B. A., Risch, N. J., Faris, G., Friedman, D., & Erlenmeyer-Kimling, L. (1988). The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Research, 26(2), 223–238.

References

  1. 1 2 Cornblatt, Barbara. "Barbara A. Cornblatt, PhD, MBA – Investigator at The Feinstein Institute | Northwell Health". The Feinstein Institute for Medical Research.
  2. ↑ "Doctors Try a Bold Move Against Schizophrenia". archive.nytimes.com. Retrieved 2020-01-25.
  3. ↑ Carey, Benedict (2006-05-23). "A Career That Has Mirrored Psychiatry's Twisting Path". The New York Times. ISSN 0362-4331. Retrieved 2020-01-25.
  4. ↑ "Recognition and Prevention Program - Understanding Psychosis". www.rapprogram.org.
  5. ↑ "Zubin Awards". www.wpic.pitt.edu. Retrieved 2020-01-25.
  6. ↑ "Society for Research in Psychopathology". Retrieved 2020-01-25.
  7. ↑ Cornblatt, Barbara. "2/3-Cognitive Behavioral Social Skills Training for Youth at Risk of Psychosis". Grantome.
  8. ↑ Cornblatt, Barbara. "4/9-Predictors and Mechanisms of Conversion to Psychosis". Grantome.
  9. ↑ Cornblatt, Barbara. "Characterization of Prodromal Schizophrenia". Grantome.
  10. ↑ Addington, Jean; Liu, Lu; Buchy, Lisa; Cadenhead, Kristin S.; Cannon, Tyrone D.; Cornblatt, Barbara A.; Perkins, Diana O.; Seidman, Larry J.; Tsuang, Ming T.; Walker, Elaine F.; Woods, Scott W. (2015). "North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms". The Journal of Nervous and Mental Disease. 203 (5): 328–335. doi:10.1097/NMD.0000000000000290. ISSN 0022-3018. PMC 4417745. PMID 25919383.
  11. ↑ Cannon, Tyrone D.; Cadenhead, Kristin; Cornblatt, Barbara; Woods, Scott W.; Addington, Jean; Walker, Elaine; Seidman, Larry J.; Perkins, Diana; Tsuang, Ming; McGlashan, Thomas; Heinssen, Robert (2008-01-01). "Prediction of Psychosis in Youth at High Clinical Risk: A Multisite Longitudinal Study in North America". Archives of General Psychiatry. 65 (1): 28–37. doi:10.1001/archgenpsychiatry.2007.3. ISSN 0003-990X. PMC 3065347. PMID 18180426.
  12. ↑ Woods, Scott W.; Addington, Jean; Cadenhead, Kristin S.; Cannon, Tyrone D.; Cornblatt, Barbara A.; Heinssen, Robert; Perkins, Diana O.; Seidman, Larry J.; Tsuang, Ming T.; Walker, Elaine F.; McGlashan, Thomas H. (2009-09-01). "Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study". Schizophrenia Bulletin. 35 (5): 894–908. doi:10.1093/schbul/sbp027. ISSN 0586-7614. PMC 2728816. PMID 19386578.
  13. ↑ Perkins, Diana O.; Jeffries, Clark D.; Addington, Jean; Bearden, Carrie E.; Cadenhead, Kristin S.; Cannon, Tyrone D.; Cornblatt, Barbara A.; Mathalon, Daniel H.; McGlashan, Thomas H.; Seidman, Larry J.; Tsuang, Ming T. (March 2015). "Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project". Schizophrenia Bulletin. 41 (2): 419–428. doi:10.1093/schbul/sbu099. ISSN 0586-7614. PMC 4332942. PMID 25103207.
  14. ↑ Walker, Elaine F.; Trotman, Hanan D.; Pearce, Brad D.; Addington, Jean; Cadenhead, Kristin S.; Cornblatt, Barbara A.; Heinssen, Robert; Mathalon, Daniel H.; Perkins, Diana O.; Seidman, Larry J.; Tsuang, Ming T.; Cannon, Tyrone D.; McGlashan, Thomas H.; Woods, Scott W. (September 15, 2013). "Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study". Biological Psychiatry. 74 (6): 410–417. doi:10.1016/j.biopsych.2013.02.016. PMC 3707958. PMID 23562006.
  15. ↑ Tarbox, Sarah I.; Addington, Jean; Cadenhead, Kristin S.; Cannon, Tyrone D.; Cornblatt, Barbara A.; Perkins, Diana O.; Seidman, Larry J.; Tsuang, Ming T.; Walker, Elaine F.; Heinssen, Robert; McGlashan, Thomas H.; Woods, Scott W. (January 30, 2014). "Functional development in clinical high risk youth: Prediction of schizophrenia versus other psychotic disorders". Psychiatry Research. 215 (1): 52–60. doi:10.1016/j.psychres.2013.10.006. PMC 3946851. PMID 24200216.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.